Navigation Links
Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets
Date:7/28/2008

- Plus, Higher then Expected MCI Prevalence Shows Urgent Need for Better Therapies -

CHICAGO, July 28 /PRNewswire-USNewswire/ -- Two studies related to experimental Alzheimer's therapies reported positive results today at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD 2008) in Chicago.

One Phase II trial, of a compound called AL-108, targeted early abnormal brain changes in a protein called "tau" in a condition related to Alzheimer's called mild cognitive impairment (MCI). The researchers saw improvement on various measures of memory. Another study examined brains of people with Alzheimer's half of whom had diabetes, and half did not. The researchers found that people in the study who took a combination of insulin and oral anti-diabetes medications had fewer Alzheimer's-related brain changes (amyloid plaques) than all the others in the study. This could be a pathway for developing new treatments.

Plus, a new study from the Mayo Clinic showed higher than expected rates of MCI in a large, older population. People with MCI have ongoing memory problems, but they do not have other losses such as confusion, attention problems, and difficulty with language. People with MCI are much more likely to get Alzheimer's than the general population.

"We are making progress. It is very important that we have as many drugs as possible in the pipeline for Alzheimer's, and that we explore every available avenue for treatments," said Ralph Nixon, MD, Ph.D., of the Alzheimer's Association's Medical and Scientific Advisory Council. "However, the population is aging, and we need to make significant advances soon in treatment and prevention of Alzheimer's or it will become an overwhelming epidemic, wiping out our healthcare resources and devastating Medicare."

Dr. Nixon is Professor of Psychiatry and Cell Biology, Vice Chairman of Research in the Department of Psychiatry, and Director of the Silberstein Instit
'/>"/>

SOURCE Alzheimer's Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
2. Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinsons Disease
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimers Drug After Flurizans Discontinuation
5. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
6. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
7. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
8. Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease
9. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
10. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
11. U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... NORTHBROOK, Ill. , July 22, 2014 /PRNewswire/ ... has announced that the U.S. Food and Drug ... standards as consensus standards for medical devices incorporating ... UL 2054 - Standard for Household and Commercial ... Batteries (Cells). Consensus standards are ...
(Date:7/22/2014)... WASHINGTON, New York , July ... Neue Partnerschaft für umfassenden Schutz ... Medikamenteneinwirkungen in Österreich    ... Anbieter von geschlossenen Transfersystemen (Closed System Transfer Devices, CSTDs) ... Medikus , einen Vertriebshändler und Hersteller ...
(Date:7/21/2014)... July 21, 2014 Thoratec Corporation (NASDAQ: ... circulatory support therapies to save, support and restore failing ... results for the second quarter of fiscal year 2014 ... hold a conference call to discuss its financial results ... 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight ...
Breaking Medicine Technology:Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices 2Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2Thoratec Schedules Second Quarter Conference Call, Webcast 2
(Date:7/22/2014)... The donation from the Edusei Foundation was ... In a feat of strategic engineering, such assistance tends to ... of the beneficiaries. It provided a sense of family to ... The Edusei Foundation donated various amounts of; milk, ... indomie. , The Government of Ghana established the Kumasi Children’s ...
(Date:7/22/2014)... New York (PRWEB) July 22, 2014 ... report published by Transparency Market Research “Circulating ... [Technologies: Tumor Cell Enrichment (Filtration, Centrifugation and ... Detection (Molecular Methods and Optical Methods) and ... and Others] - Global Industry Analysis, Size, ...
(Date:7/22/2014)... 22, 2014 Hospitals & ... was conducted by Hospitals & Health Networks ... AT&T, CareTech Solutions, The College of Healthcare ... Wired list recognizes hospitals for successful health ... hospitals in four focus areas: business and ...
(Date:7/22/2014)... July 22, 2014 Over the ... almost every sphere of human anatomy. In the ... advancements that rendered the possibility of deploying certain ... blood and tissues, in order to detect the ... abnormality. Essentially, In-vitro Diagnostics (IVD) have earned the ...
(Date:7/22/2014)... -- People who suffer long-term sleep problems after a ... pressure, a new study suggests. Previous research has ... death, but few studies have examined the reasons for ... causes, according to the University of Arizona investigators. ... or divorced for about 16 weeks. They reported on ...
Breaking Medicine News(10 mins):Health News:Edusei Foundation Donates Food and Needed Items to Kumasi Children’s Home in Ashanti Region of Ghana 2Health News:Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020 2Health News:Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020 3Health News:Circulating Tumor Cells (CTCs) Prognostic Technologies Market Expected to Reach USD 2.16 Billion Globally in 2020 4Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 2Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 3Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 4Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 2Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 3Health News:Global Molecular Diagnostics Market Report 2014 Edition Now Available at MarketReportsOnline.com 4Health News:Sleepless Nights After Divorce May Be Tied to Blood Pressure Rise 2
... Oct. 6 The following is a,transcript of a ... THE PRESIDENT: Good morning., One important commitment of ... access to health care. Most of these children are,covered ... to help them,this fiscal year. For children who do ...
... 5 Marion Jones-Thompson, 31,of Austin, Texas, pleaded ... federal agencies in connection with two investigations,conducted out ... the Northern,District of California, respectively; Michael J. Garcia, ... New York; and Scott N. Schools, the,United States ...
... , Why: According to the Department of Defense, the signature ... in the conflicts in Iraq and Afghanistan ... survivors at risk of TBI. Government reports cite ... 5,500 service members with the potential ...
... Advance Heart Care Treatment, Physician Program at Montefiore Will, ... Satisfaction, NEW YORK, Oct. 5 Thousands of ... top quality, comprehensive,cardiac care in an innovative cardiovascular program ... receive incentive payments based on 60,performance measures for outpatient ...
... aspects to creating an effective drug: finding a chemical ... side-effects and then delivering it to the right place ... With the support from a $478,000, five-year CAREER award ... the second part of this problem. She is creating ...
... AUSTIN, Texas, Oct. 5 AARP today said a,proposed ... amounts,to one more backroom deal that ignores the interests ... new debt for a mere,one-time $15 electric bill credit. ... Jackson, AARP Texas,state director. "They,ll be the ones having ...
Cached Medicine News:Health News:Radio Address by President Bush to the Nation 2Health News:Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations 2Health News:Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations 3Health News:Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations 4Health News:Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations 5Health News:Easter Seals Launches Program for Veterans Returning from Iraq and Afghanistan with Traumatic Brain Injuries 2Health News:Easter Seals Launches Program for Veterans Returning from Iraq and Afghanistan with Traumatic Brain Injuries 3Health News:Novel Approach to Improving Cardiovascular Care 2Health News:Novel Approach to Improving Cardiovascular Care 3Health News:Novel Approach to Improving Cardiovascular Care 4Health News:Developing a modular, nanoparticle drug delivery system 2Health News:Developing a modular, nanoparticle drug delivery system 3Health News:AARP Calls on State Regulators to Reject Proposed Settlement of TXU Buyout 2
Double-ended. 5 mm x 7 mm tips. Designated most popular model or size....
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Double-ended. 6 mm x 9 mm and 6 mm x 11 mm tips....
Designated most popular model or size. 3 mm tip....
Medicine Products: